Global Small Interfering RNA (siRNA) Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 89
Published Date: 19 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Small Interfering RNA (siRNA) Drugs market size was valued at USD 1035.6 million in 2023 and is forecast to a readjusted size of USD 5308.7 million by 2030 with a CAGR of 26.3% during review period.
Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively "silencing" the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.
The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.
The Global Info Research report includes an overview of the development of the Small Interfering RNA (siRNA) Drugs industry chain, the market status of AHP (GIVLAARI, Onpattro), hATTR (GIVLAARI, Onpattro), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Interfering RNA (siRNA) Drugs.
Regionally, the report analyzes the Small Interfering RNA (siRNA) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Interfering RNA (siRNA) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Small Interfering RNA (siRNA) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Interfering RNA (siRNA) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., GIVLAARI, Onpattro).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Interfering RNA (siRNA) Drugs market.
Regional Analysis: The report involves examining the Small Interfering RNA (siRNA) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Interfering RNA (siRNA) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Small Interfering RNA (siRNA) Drugs:
Company Analysis: Report covers individual Small Interfering RNA (siRNA) Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Interfering RNA (siRNA) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (AHP, hATTR).
Technology Analysis: Report covers specific technologies relevant to Small Interfering RNA (siRNA) Drugs. It assesses the current state, advancements, and potential future developments in Small Interfering RNA (siRNA) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Interfering RNA (siRNA) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Small Interfering RNA (siRNA) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
GIVLAARI
Onpattro
OXLUMO
AMVUTTRA
Leqvio
Market segment by Application
AHP
hATTR
Other
Market segment by players, this report covers
Alnylam
Novartis
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Small Interfering RNA (siRNA) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Interfering RNA (siRNA) Drugs, with revenue, gross margin and global market share of Small Interfering RNA (siRNA) Drugs from 2019 to 2024.
Chapter 3, the Small Interfering RNA (siRNA) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Small Interfering RNA (siRNA) Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Interfering RNA (siRNA) Drugs.
Chapter 13, to describe Small Interfering RNA (siRNA) Drugs research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Small Interfering RNA (siRNA) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Interfering RNA (siRNA) Drugs by Type
1.3.1 Overview: Global Small Interfering RNA (siRNA) Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type in 2023
1.3.3 GIVLAARI
1.3.4 Onpattro
1.3.5 OXLUMO
1.3.6 AMVUTTRA
1.3.7 Leqvio
1.4 Global Small Interfering RNA (siRNA) Drugs Market by Application
1.4.1 Overview: Global Small Interfering RNA (siRNA) Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 AHP
1.4.3 hATTR
1.4.4 Other
1.5 Global Small Interfering RNA (siRNA) Drugs Market Size & Forecast
1.6 Global Small Interfering RNA (siRNA) Drugs Market Size and Forecast by Region
1.6.1 Global Small Interfering RNA (siRNA) Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Small Interfering RNA (siRNA) Drugs Market Size by Region, (2019-2030)
1.6.3 North America Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2019-2030)
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam Small Interfering RNA (siRNA) Drugs Product and Solutions
2.1.4 Alnylam Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Small Interfering RNA (siRNA) Drugs Product and Solutions
2.2.4 Novartis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Sylentis
2.3.1 Sylentis Details
2.3.2 Sylentis Major Business
2.3.3 Sylentis Small Interfering RNA (siRNA) Drugs Product and Solutions
2.3.4 Sylentis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sylentis Recent Developments and Future Plans
2.4 Arrowhead
2.4.1 Arrowhead Details
2.4.2 Arrowhead Major Business
2.4.3 Arrowhead Small Interfering RNA (siRNA) Drugs Product and Solutions
2.4.4 Arrowhead Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Arrowhead Recent Developments and Future Plans
2.5 Silence Therapeutics
2.5.1 Silence Therapeutics Details
2.5.2 Silence Therapeutics Major Business
2.5.3 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product and Solutions
2.5.4 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Silence Therapeutics Recent Developments and Future Plans
2.6 Dicerna
2.6.1 Dicerna Details
2.6.2 Dicerna Major Business
2.6.3 Dicerna Small Interfering RNA (siRNA) Drugs Product and Solutions
2.6.4 Dicerna Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dicerna Recent Developments and Future Plans
3.1 Global Small Interfering RNA (siRNA) Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Small Interfering RNA (siRNA) Drugs by Company Revenue
3.2.2 Top 3 Small Interfering RNA (siRNA) Drugs Players Market Share in 2023
3.2.3 Top 6 Small Interfering RNA (siRNA) Drugs Players Market Share in 2023
3.3 Small Interfering RNA (siRNA) Drugs Market: Overall Company Footprint Analysis
3.3.1 Small Interfering RNA (siRNA) Drugs Market: Region Footprint
3.3.2 Small Interfering RNA (siRNA) Drugs Market: Company Product Type Footprint
3.3.3 Small Interfering RNA (siRNA) Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Small Interfering RNA (siRNA) Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Small Interfering RNA (siRNA) Drugs Market Forecast by Type (2025-2030)
5.1 Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Small Interfering RNA (siRNA) Drugs Market Forecast by Application (2025-2030)
6.1 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2030)
6.2 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2030)
6.3 North America Small Interfering RNA (siRNA) Drugs Market Size by Country
6.3.1 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
7.1 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2030)
7.2 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2030)
7.3 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country
7.3.1 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
7.3.3 France Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region
8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2019-2030)
8.3.2 China Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
8.3.5 India Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
9.1 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2030)
9.2 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2030)
9.3 South America Small Interfering RNA (siRNA) Drugs Market Size by Country
9.3.1 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country
10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2019-2030)
11.1 Small Interfering RNA (siRNA) Drugs Market Drivers
11.2 Small Interfering RNA (siRNA) Drugs Market Restraints
11.3 Small Interfering RNA (siRNA) Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Small Interfering RNA (siRNA) Drugs Industry Chain
12.2 Small Interfering RNA (siRNA) Drugs Upstream Analysis
12.3 Small Interfering RNA (siRNA) Drugs Midstream Analysis
12.4 Small Interfering RNA (siRNA) Drugs Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Alnylam Company Information, Head Office, and Major Competitors
Table 6. Alnylam Major Business
Table 7. Alnylam Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 8. Alnylam Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Alnylam Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 13. Novartis Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Sylentis Company Information, Head Office, and Major Competitors
Table 16. Sylentis Major Business
Table 17. Sylentis Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 18. Sylentis Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sylentis Recent Developments and Future Plans
Table 20. Arrowhead Company Information, Head Office, and Major Competitors
Table 21. Arrowhead Major Business
Table 22. Arrowhead Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 23. Arrowhead Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Arrowhead Recent Developments and Future Plans
Table 25. Silence Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Silence Therapeutics Major Business
Table 27. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 28. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Silence Therapeutics Recent Developments and Future Plans
Table 30. Dicerna Company Information, Head Office, and Major Competitors
Table 31. Dicerna Major Business
Table 32. Dicerna Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 33. Dicerna Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Dicerna Recent Developments and Future Plans
Table 35. Global Small Interfering RNA (siRNA) Drugs Revenue (USD Million) by Players (2019-2024)
Table 36. Global Small Interfering RNA (siRNA) Drugs Revenue Share by Players (2019-2024)
Table 37. Breakdown of Small Interfering RNA (siRNA) Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Small Interfering RNA (siRNA) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 39. Head Office of Key Small Interfering RNA (siRNA) Drugs Players
Table 40. Small Interfering RNA (siRNA) Drugs Market: Company Product Type Footprint
Table 41. Small Interfering RNA (siRNA) Drugs Market: Company Product Application Footprint
Table 42. Small Interfering RNA (siRNA) Drugs New Market Entrants and Barriers to Market Entry
Table 43. Small Interfering RNA (siRNA) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Small Interfering RNA (siRNA) Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 45. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Type (2019-2024)
Table 46. Global Small Interfering RNA (siRNA) Drugs Consumption Value Forecast by Type (2025-2030)
Table 47. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2024)
Table 48. Global Small Interfering RNA (siRNA) Drugs Consumption Value Forecast by Application (2025-2030)
Table 49. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 50. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 51. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 52. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 53. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 54. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 55. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 58. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 59. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 62. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 63. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 64. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 65. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 67. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 68. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 69. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 70. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 71. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 72. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 74. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 75. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 76. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 77. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 78. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Small Interfering RNA (siRNA) Drugs Raw Material
Table 80. Key Suppliers of Small Interfering RNA (siRNA) Drugs Raw Materials
List of Figures
Figure 1. Small Interfering RNA (siRNA) Drugs Picture
Figure 2. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type in 2023
Figure 4. GIVLAARI
Figure 5. Onpattro
Figure 6. OXLUMO
Figure 7. AMVUTTRA
Figure 8. Leqvio
Figure 9. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application in 2023
Figure 11. AHP Picture
Figure 12. hATTR Picture
Figure 13. Other Picture
Figure 14. Global Small Interfering RNA (siRNA) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Small Interfering RNA (siRNA) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Small Interfering RNA (siRNA) Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region in 2023
Figure 19. North America Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Small Interfering RNA (siRNA) Drugs Revenue Share by Players in 2023
Figure 25. Small Interfering RNA (siRNA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Small Interfering RNA (siRNA) Drugs Market Share in 2023
Figure 27. Global Top 6 Players Small Interfering RNA (siRNA) Drugs Market Share in 2023
Figure 28. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Type (2019-2024)
Figure 29. Global Small Interfering RNA (siRNA) Drugs Market Share Forecast by Type (2025-2030)
Figure 30. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Application (2019-2024)
Figure 31. Global Small Interfering RNA (siRNA) Drugs Market Share Forecast by Application (2025-2030)
Figure 32. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. France Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 49. China Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. India Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Small Interfering RNA (siRNA) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 66. Small Interfering RNA (siRNA) Drugs Market Drivers
Figure 67. Small Interfering RNA (siRNA) Drugs Market Restraints
Figure 68. Small Interfering RNA (siRNA) Drugs Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Small Interfering RNA (siRNA) Drugs in 2023
Figure 71. Manufacturing Process Analysis of Small Interfering RNA (siRNA) Drugs
Figure 72. Small Interfering RNA (siRNA) Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Alnylam Novartis Sylentis Arrowhead Silence Therapeutics Dicerna
Related Reports
08 Nov 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
